Statin exposure and thrombosis risk in patients with myeloproliferative neoplasms

被引：2
|
作者：
Delluc, Aurelien [1 ,2 ,6 ]
Lacut, Karine [1 ,3 ]
Pan-Petesch, Brigitte [1 ,4 ]
Galinat, Hubert [1 ,4 ]
Lippert, Eric [5 ]
Ianotto, Jean-Christophe [1 ,4 ]
机构：
[1] Brest Univ, EA GETBO 3878, F-29200 Brest, France
[2] Hop Cavale Blanche, Dept Chest Dis & Internal Med, F-29609 Brest, France
[3] Hop Cavale Blanche, INSERM CIC 1412, F-29609 Brest, France
[4] Hop Morvan, Oncol & Hematol Inst, F-29609 Brest, France
[5] Brest Univ, IBSAM, Genet Genom Fonct & Biotechnol UMR1078, Lab Hematol,Equipe ECLA, F-29200 Brest, France
[6] Ottawa Hosp, Ottawa Hosp Res Inst, Clin Epidemiol Program, Div Clin Hematol, Box 201B,501 Smyth Rd, Ottawa, ON K1H 8L6, Canada
来源：
THROMBOSIS RESEARCH | 2018年 / 167卷
关键词：
VENOUS THROMBOEMBOLISM; CANCER; COHORT;
D O I：
10.1016/j.thromres.2018.05.014
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：57 / 59
页数：3
相关论文
共 50 条
  • [31] Defining the Thrombotic Risk in Patients with Myeloproliferative Neoplasms
    Vianello, Fabrizio
    Battisti, Anna
    Cella, Giuseppe
    Marchetti, Marina
    Falanga, Anna
    THESCIENTIFICWORLDJOURNAL, 2011, 11 : 1131 - 1137
  • [32] Splanchnic Vein Thrombosis in the Myeloproliferative Neoplasms
    Akpan, Imo J.
    Stein, Brady Lee
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2018, 13 (03) : 183 - 190
  • [33] Splanchnic Vein Thrombosis in the Myeloproliferative Neoplasms
    Imo J. Akpan
    Brady Lee Stein
    Current Hematologic Malignancy Reports, 2018, 13 : 183 - 190
  • [34] Thrombosis in myeloproliferative neoplasms: update in pathophysiology
    Reeves, Brandi N.
    Moliterno, Alison R.
    CURRENT OPINION IN HEMATOLOGY, 2021, 28 (05) : 285 - 291
  • [35] How to manage thrombosis in myeloproliferative neoplasms
    Barbui, Tiziano
    CURRENT OPINION IN ONCOLOGY, 2011, 23 (06) : 654 - 658
  • [36] Risk factors of thrombosis in a cohort of 206 patients with BCR-ABL1 negative myeloproliferative neoplasms
    Aswad, Mohamed Hussam
    Kissova, Jarmila
    Ovesna, Petra
    Penka, Miroslav
    NEOPLASMA, 2021, 68 (06) : 1341 - 1350
  • [37] ANALYSIS OF THE RISK OF THROMBOSIS IN PATIENTS WITH CHRONIC MYELOPROLIFERATIVE NEOPLASMS AND MUTATION OF THE JAK2 AND MPL GENES
    Sagues, M.
    Xicoy, B.
    Estrada, N.
    Zamora, L.
    Buxo, M.
    Bustins, A.
    Diaz, J.
    Coll, R.
    Guardia, R.
    Cruz, D.
    Moret, C.
    Roncero, J. M.
    Gonzalez, Y.
    Santos, N.
    Blanco, A.
    Kelleher, N.
    Lloveras, N.
    Mostacedo, S.
    Buch, J.
    Costa, P.
    Tejerina, P.
    Marull, A.
    Serrando, M.
    Tuset, E.
    Gallardo, D.
    HAEMATOLOGICA, 2017, 102 : 278 - 279
  • [38] Increased Risk of Thrombosis in Patients with Myeloproliferative Neoplasms Compared with the General Population Hospitalized with COVID-19
    Leiva, Orly
    Campia, Umberto
    Snyder, Julia
    Barns, Briana
    Rizzo, Samantha
    Khairani, Candrika
    Al-Samkari, Hanny
    Leaf, Rebecca Karp
    Rosovsky, Rachel P.
    Goodarzi, Katayoon
    Fathi, Amir T.
    Goldhaber, Samuel Z.
    Piazza, Gregory
    Hobbs, Gabriela
    BLOOD, 2021, 138
  • [39] Deciphering the Individual Contribution of Absolute Neutrophil, Lymphocyte and Monocyte Counts to Thrombosis Risk in Patients with Myeloproliferative Neoplasms
    Farrukh, Faiqa
    Guglielmelli, Paola
    Loscocco, Giuseppe Gaetano
    Pardanani, Animesh D.
    Hanson, Curtis A.
    De Stefano, Valerio
    Barbui, Tiziano
    Gangat, Naseema
    Vannucchi, Alessandro M.
    Tefferi, Ayalew
    BLOOD, 2021, 138
  • [40] STUDY OF MUTATIONAL PROFILE IN MYELOPROLIFERATIVE NEOPLASMS PATIENTS WITH SPLANCHNIC VEIN THROMBOSIS
    Mannarelli, C.
    Pacilli, A.
    Rotunno, G.
    Sant'Antonio, E.
    Loscocco, G. G.
    Coltro, G.
    Sordi, B.
    Demarcus, N.
    Vannucchi, A. M.
    Guglielmelli, P.
    HAEMATOLOGICA, 2020, 105 : S66 - S66
12345